Promentis Pharmaceuticals
Developing therapies for neuropsychiatric and neurodevelopmental disorders.
F-Prime Team
Sector
Life SciencesCategory
TherapeuticsLocation
Milwaukee, WisconsinInitial Investment
2016
Developing therapies for neuropsychiatric and neurodevelopmental disorders.
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company, is developing innovative therapies for neuropsychiatric disorders.